Ilika plc (LON:IKA), an independent global expert in solid-state battery technology, has provided updates on trading, Stereax® manufacturing, and Goliath product development, as well as notice of its full year results for the year ended 30 April 2024.
Trading Update for FY24
Unaudited trading for the year ended 30 April 2024 has been in line with management expectations. The Company expects to announce revenues of approximately £2.1m (2023: £0.7m), and an EBITDA loss excluding share-based payments of around £4.5m (2023: EBITDA loss of £7m). Cash and cash equivalents at the period end were £11.9m (30 April 2023: £15.8m).
Operational Update
During the Period, significant progress was made with transferring manufacturing to Cirtec Medical LLC under the licence of Ilika’s thin-film Stereax miniature solid-state batteries for powering medical devices and industrial wireless sensors in specialist environments